Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption.


Journal

Journal of lipid research
ISSN: 1539-7262
Titre abrégé: J Lipid Res
Pays: United States
ID NLM: 0376606

Informations de publication

Date de publication:
07 2019
Historique:
received: 18 02 2019
revised: 02 05 2019
pubmed: 3 5 2019
medline: 14 7 2020
entrez: 4 5 2019
Statut: ppublish

Résumé

Monoacylglycerol lipase (MGL) is the rate-limiting enzyme in the degradation of monoacylglycerols. To examine the role of MGL in hepatic steatosis, WT and MGL KO (MGL

Identifiants

pubmed: 31048404
pii: S0022-2275(20)31060-9
doi: 10.1194/jlr.M093369
pmc: PMC6602129
doi:

Substances chimiques

Adiponectin 0
Fatty Acids 0
Insulin 0
Peroxisome Proliferator-Activated Receptors 0
Triglycerides 0
Monoacylglycerol Lipases EC 3.1.1.23
Glycerol PDC6A3C0OX
3-Hydroxybutyric Acid TZP1275679

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1284-1292

Informations de copyright

Copyright © 2019 Tardelli et al.

Références

Endocr Rev. 1999 Oct;20(5):649-88
pubmed: 10529898
J Endocrinol. 2001 Jun;169(3):453-9
pubmed: 11375115
N Engl J Med. 2002 Apr 18;346(16):1221-31
pubmed: 11961152
Biochemistry. 2002 May 28;41(21):6640-50
pubmed: 12022867
J Biol Chem. 2002 Dec 20;277(51):49776-81
pubmed: 12351639
Gastroenterology. 2002 Oct;123(4):1238-51
pubmed: 12360485
J Clin Endocrinol Metab. 2004 Feb;89(2):463-78
pubmed: 14764748
Gastroenterology. 2004 Jul;127(1):139-44
pubmed: 15236180
Gastroenterology. 2004 Jul;127(1):261-74
pubmed: 15236191
Diabetes. 2006 Jun;55(6):1537-45
pubmed: 16731815
Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1736-45
pubmed: 17848638
Biochem J. 2003 Nov 1;375(Pt 3):539-49
pubmed: 18320708
Prog Lipid Res. 2009 Jan;48(1):1-26
pubmed: 18824034
Cell. 2008 Oct 17;135(2):240-9
pubmed: 18835024
Am J Physiol Gastrointest Liver Physiol. 2008 Dec;295(6):G1255-65
pubmed: 18948437
Nat Chem Biol. 2009 Jan;5(1):37-44
pubmed: 19029917
Biochim Biophys Acta. 2010 Mar;1801(3):299-310
pubmed: 19857603
Mol Pharmacol. 2010 Dec;78(6):996-1003
pubmed: 20855465
J Lipid Res. 2011 Apr;52(4):657-67
pubmed: 21317108
J Biol Chem. 2011 May 20;286(20):17467-77
pubmed: 21454566
PLoS One. 2011 Mar 29;6(3):e18222
pubmed: 21479238
J Biomed Biotechnol. 2011;2011:598358
pubmed: 21960738
PLoS One. 2012;7(8):e43962
pubmed: 22937137
Gastroenterology. 2013 Apr;144(4):808-817.e15
pubmed: 23295443
J Lipid Res. 2015 Jun;56(6):1153-71
pubmed: 25842377
J Gastroenterol Hepatol. 2017 Jan;32(1):253-260
pubmed: 27083512
Hepatology. 2017 Jun;65(6):1875-1890
pubmed: 28073161
Nat Commun. 2017 Mar 22;8:14859
pubmed: 28327588
Oncotarget. 2017 May 16;8(20):33122-33136
pubmed: 28380440
Biochem Biophys Res Commun. 2017 Aug 12;490(1):51-54
pubmed: 28595905
World J Hepatol. 2017 Jun 8;9(16):715-732
pubmed: 28652891
Hepatology. 2018 Jan;67(1):123-133
pubmed: 28802062
Diabetes Obes Metab. 2017 Sep;19 Suppl 1:76-89
pubmed: 28880480
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20
pubmed: 28930295
Obes Res Clin Pract. 2018 May - Jun;12(3):277-285
pubmed: 29519755
Gut. 2018 Sep;67(9):1683-1691
pubmed: 29636383
Gut. 2018 Oct 9;:null
pubmed: 30301768

Auteurs

Matteo Tardelli (M)

Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Francesca V Bruschi (FV)

Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Thierry Claudel (T)

Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Claudia D Fuchs (CD)

Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Nicole Auer (N)

Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Victoria Kunczer (V)

Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Tatjana Stojakovic (T)

Clinical Institute of Medical and Chemical Laboratory Diagnostics University Hospital Graz, Graz, Austria.

Hubert Scharnagl (H)

Clinical Institute of Medical and Chemical Laboratory Diagnostics Medical University of Graz, Graz, Austria.

Aida Habib (A)

INSERM-UMR1149, Centre de Recherche sur l'Inflammation, Paris, France.
Department of Biochemistry and Molecular Genetics American University of Beirut, Beirut, Lebanon.

Gernot F Grabner (GF)

Institute of Molecular Biosciences University of Graz, Graz, Austria.

Robert Zimmermann (R)

Institute of Molecular Biosciences University of Graz, Graz, Austria.

Sophie Lotersztajn (S)

INSERM-UMR1149, Centre de Recherche sur l'Inflammation, Paris, France.

Michael Trauner (M)

Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria michael.trauner@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH